CVN058 Effect on Mismatch Negativity in Schizophrenics

NCT03669250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: CVN058
OTHER: Placebo comparator

Sponsor

Cerevance Alpha, Inc.